Amgen (AMGN) Tops Q1 EPS by 16c
Tweet
Share
E-mail_58cbc46cd3c33.jpg)
Get Alerts AMGN Hot Sheet
Price: $437.23 -1.55%
Revenue Growth %: +5.1%
Financial Fact:
Income before income taxes: 2.42B
Today's EPS Names:
PMCB, CULP, HURC, More
Revenue Growth %: +5.1%
Financial Fact:
Income before income taxes: 2.42B
Today's EPS Names:
PMCB, CULP, HURC, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q1 EPS of $3.98, $0.16 better than the analyst estimate of $3.82. Revenue for the quarter came in at $6.1 billion versus the consensus estimate of $6.12 billion.
GUIDANCE:
Amgen sees FY 2023 EPS of $17.60-$18.70, versus the consensus of $17.72. Amgen sees FY 2023 revenue of $26.2-27.3 billion, versus the consensus of $26.7 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Ardent Health revises 2025 non-GAAP figures after SEC staff talks
- UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
